Zimbabwe has declined a substantial US healthcare agreement valued at 367 million US dollars (£272m) spanning five years over Washington's demand for sensitive information.
This move came to light following a official document dated December was disclosed, indicating that President Emmerson Mnangagwa felt the agreement was "skewed".
An official spokesman later stated that the US was requesting genetic material for research and commercial purposes while refused to share the benefits from any future medical innovations.
"We are forced to start the challenging and unfortunate process of winding down our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy said the US had provided more than $1.9bn for health programmes to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has urged further negotiations to reach a deal acceptable to all parties so the nation's critical HIV programme can be sustained.
Broader Implications
This rejection comes after a comparable case in neighbouring Kenya, where a court blocked a related health funding agreement following legal challenges were raised about the security of citizens' medical information.
Since returning to the presidency recently, US President Donald Trump has drastically cut overseas assistance and closed the key foreign aid agency.
The agency had administered assistance for the American government, but Trump argued its expenditure was "inefficient" and his administration was pursuing direct bilateral deals to enhance openness and accountability.
As per statements, 16 African countries have to date agreed to these new agreements, constituting over $18.3bn in new funding.
Details of the Rejected Deal
The money for Zimbabwe would have funded "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We believe this cooperation could have provided extraordinary benefits for the people of Zimbabwe, especially the 1.2 million men, women and children currently on HIV treatment through American-funded initiatives," the Ambassador commented.
However, official spokesman Nick Mangwana argued the proposed deal was "asymmetrical".
"The proposal required Zimbabwe to surrender its genetic material and health information for a long time, with no corresponding promise of access to any medical innovations – such as new medicines or tests – that could be developed from that shared data," Mangwana explained.
"Effectively, our country would provide the raw materials for medical research with no assurance that the end products would be accessible to our people should a future health crisis arise."
Sovereignty and International Frameworks
Mangwana further pointed out that the American exit from the global health body and its pursuit of bilateral deals were disrupting frameworks previously established through the global organization.
Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme designed to manage potential pandemics.
"This mechanism is designed to ensure that when a country provides its information, the resulting advantages – including vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the capability to develop them."
Zimbabwe's reservations regarding the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.
"We encourage continued dialogue with our US partners on how subsequent collaboration could be structured in a way that respects the sovereignty and dignity of both nations."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it acknowledged the official position, but urged that talks should continue considering much of the country's HIV programmes depended on foreign aid.
"If specific concerns exist, including those involving information security or implementation frameworks, these can often be resolved via technical clarification and negotiated safeguards," it commented.
The situation underscores the continuing debate between accepting crucial foreign assistance and safeguarding national sovereignty in an ever more data-driven world.